×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TELO – telomir pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TELO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/23
07:46 am
telo
Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson's Disease [Yahoo! Finance]
Medium
Report
Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson's Disease [Yahoo! Finance]
12/23
07:30 am
telo
Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson's Disease
Medium
Report
Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson's Disease
12/23
06:50 am
telo
EXCLUSIVE: Telomir Pharmaceuticals Reports Potential Of Telomir-1 For Wilson's Disease [Yahoo! Finance]
High
Report
EXCLUSIVE: Telomir Pharmaceuticals Reports Potential Of Telomir-1 For Wilson's Disease [Yahoo! Finance]
12/12
08:52 am
telo
Telomir Pharmaceuticals Raises $1 Million at $7 per Share in a No-Warrant, Restricted Common Stock Deal, Representing a 20% Premium to Closing Price [Yahoo! Finance]
Medium
Report
Telomir Pharmaceuticals Raises $1 Million at $7 per Share in a No-Warrant, Restricted Common Stock Deal, Representing a 20% Premium to Closing Price [Yahoo! Finance]
12/12
08:30 am
telo
Telomir Pharmaceuticals Raises $1 Million at $7 per Share in a No-Warrant, Restricted Common Stock Deal, Representing a 20% Premium to Closing Price
High
Report
Telomir Pharmaceuticals Raises $1 Million at $7 per Share in a No-Warrant, Restricted Common Stock Deal, Representing a 20% Premium to Closing Price
12/3
07:50 am
telo
Telomir Pharmaceuticals Announces Reversal of Key Type 2 Diabetes Parameters in Groundbreaking Preclinical Study With Telomir-1 [Yahoo! Finance]
Medium
Report
Telomir Pharmaceuticals Announces Reversal of Key Type 2 Diabetes Parameters in Groundbreaking Preclinical Study With Telomir-1 [Yahoo! Finance]
12/3
07:30 am
telo
Telomir Pharmaceuticals Announces Reversal of Key Type 2 Diabetes Parameters in Groundbreaking Preclinical Study With Telomir-1
High
Report
Telomir Pharmaceuticals Announces Reversal of Key Type 2 Diabetes Parameters in Groundbreaking Preclinical Study With Telomir-1
11/21
07:21 am
telo
Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1 [Yahoo! Finance]
Low
Report
Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1 [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/23
07:00 am
telo
Form 8-K Telomir Pharmaceuticals, For: Dec 23
High
Report
Form 8-K Telomir Pharmaceuticals, For: Dec 23
12/20
05:01 pm
telo
Form 8-K Telomir Pharmaceuticals, For: Dec 16
High
Report
Form 8-K Telomir Pharmaceuticals, For: Dec 16
12/11
04:01 pm
telo
Form 8-K Telomir Pharmaceuticals, For: Dec 09
Low
Report
Form 8-K Telomir Pharmaceuticals, For: Dec 09
12/2
04:01 pm
telo
Form 8-K Telomir Pharmaceuticals, For: Dec 02
High
Report
Form 8-K Telomir Pharmaceuticals, For: Dec 02
11/25
05:06 pm
telo
Form 4 Telomir Pharmaceuticals, For: Nov 21 Filed by: Bay Shore Trust
Low
Report
Form 4 Telomir Pharmaceuticals, For: Nov 21 Filed by: Bay Shore Trust
11/21
04:16 pm
telo
Form 8-K Telomir Pharmaceuticals, For: Nov 18
Low
Report
Form 8-K Telomir Pharmaceuticals, For: Nov 18
11/20
04:16 pm
telo
Form 8-K Telomir Pharmaceuticals, For: Nov 20
Medium
Report
Form 8-K Telomir Pharmaceuticals, For: Nov 20
11/12
04:06 pm
telo
Form 10-Q Telomir Pharmaceuticals, For: Sep 30
Medium
Report
Form 10-Q Telomir Pharmaceuticals, For: Sep 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: